Skip to main content

Table 1 Associations of patient characteristics with the TLI status.

From: Is the thymidine labeling index a good prognostic marker in breast cancer?

 

All patients

Patients with TLI-low

Patients with TLI-high

p-value

 

n

%

n

%

n

%

 

Age

      

0.900

≤50 years

136

50.7

52

38.2

84

61.8

 

>50 years

132

49.3

52

39.4

80

60.6

 

Menopausal status

      

0.559

Premenopausal

105

39.5

38

36.2

67

63.8

 

Postmenopausal

161

60.5

64

39.8

97

60.2

 

Tumor

      

0.306

pT1

103

38.4

44

42.7

59

57.3

 

pT2+pT3+pT4

165

61.6

60

36.4

105

63.6

 

Node

      

0.448

pN0

114

42.5

41

36.0

73

64.0

 

pN(+)

154

57.5

63

40.9

91

59.1

 

Stage

      

0.596

I

54

20.1

18

33.3

36

66.7

 

II

138

51.5

54

39.1

84

60.9

 

III

76

28.4

32

42.1

44

57.9

 

Type of surgery

      

0.330

Breast conservation

86

32.1

37

43.0

49

57.0

 

Mastectomy

182

67.9

67

36.8

115

63.2

 

Radiation therapy

      

0.911

Yes

200

74.6

78

39.0

122

61.0

 

No

68

25.4

26

38.2

42

61.8

 

Hormonal Therapy

      

0.021

Yes

187

69.8

81

43.3

106

56.7

 

No

81

30.2

23

28.4

58

71.6

 

Chemotherapy

      

0.451

Yes

205

76.5

77

37.6

128

62.4

 

No

63

23.5

27

42.9

36

57.1